Syria vs WPR: Hepatitis B surface antigen (HBsAg) prevalence
Syria
2.9%
in 2024
WPR
0.4%
in 2024
Syria rank
6th
WPR rank
6th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Syria
- WPR
How they compare
Syria currently reports 2.9% against 0.4% in WPR, a difference of 2.5%.
That makes Syria's figure about 7.2 times WPR's.
Across all 10 years both countries report, Syria has been ahead every year.
Syria ranks 6th and WPR ranks 6th of 194 countries.
Syria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Syria | WPR | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.5% | 0.4% | 3.1% | Syria |
| 2020s | 3.4% | 0.4% | 3.0% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Syria or WPR?
- Syria, at 2.9% against 0.4% in WPR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Syria and WPR?
- 2.5%, with Syria ahead.
- How many years of comparable data are there for Syria and WPR?
- 10 years are reported by both, from 2015 to 2024.
- How do Syria and WPR rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Syria ranks 6th and WPR ranks 6th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.